Sort
82,697 grants matching “vaccine development”
A universal malaria T cell vaccine based on HLA-E presentation
$771,027Brandon Keith Wilder · Oregon Health & Science University · R01 · FY2023 · AI
The influence of rectal Chlamydia trachomatis infections on immunity and incident urogenital infections in women without an indication forrectal screening
$770,933Stephen J. Jordan · Indiana University Indianapolis · R01 · FY2023 · AI
Building the foundations of commensal vaccines
$770,910Michael Andrew Fischbach · Stanford University · R01 · FY2023 · AI
Clinical Trials of Immunotherapies for Childhood Cancer
$770,902Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
$770,866David M. Margolis · Univ Of North Carolina Chapel Hill · R01 · FY2017 · HL
A seek, test, and treat intervention to reduce Chlamydia trachomatis disparities in Black youth living in the deep South
$770,842Patricia J Kissinger · Tulane University Of Louisiana · R01 · FY2024 · AI
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection
$770,818Priyamvada Acharya · Duke University · R01 · FY2023 · AI
Research Project 3: siRNA Therapy and Small Molecule Combination Treatment for Filoviruses
$770,799Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2021 · AI
Statistical Issues in AIDS Research
$770,776James P Hughes · University Of Washington · R37 · FY2019 · AI
Human methamphetamine vaccine: Translational Avante Garde Award
$770,762Thomas Richard Kosten · Baylor College Of Medicine · DP1 · FY2015 · DA
The development of a recombinant vaccine against human onchocerciasis
$770,747Sara Lustigman · New York Blood Center · R01 · FY2017 · AI
Effect of immunization route and prior immunity for a live attenuated varicella AIDS vaccine
$770,726Vicki L Traina-Dorge · Tulane University Of Louisiana · R01 · FY2019 · AI
Antibody mediated protective immunity against cholera
$770,722Jason B Harris · Massachusetts General Hospital · R01 · FY2020 · AI
Development of IMPDH-Targeted Drugs against Crytosporidium
$770,714Lizbeth K. Hedstrom · Brandeis University · U01 · FY2008 · AI
Task A05: Small animal models for cytomegalovirus and herpes simplex viruses
$770,712David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2021 · AI
A novel APOBEC-based vaccine approach for HIV
$770,701Douglas F Nixon · George Washington University · R33 · FY2014 · AI
Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms
$770,698Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · MH
Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection
$770,606Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Centralized IIS-Based Reminder-Recall to Increase Influenza Vaccination Rates
$770,494Allison Kempe · University Of Colorado Denver · R01 · FY2015 · AI
CAP: Trivalent Filovirus Vaccine for Pre- and Post-Exposure Vaccination
$770,440Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
$770,343Mihai Luchian Azoitei · Duke University · R01 · FY2023 · AI
Baylor College of Medicine Clinical Trial Unit
$770,321William Thomas Shearer · Baylor College Of Medicine · U01 · FY2011 · AI
International Collaboration in Infectious Disease Research on Lassa fever
$770,315Robert F Garry · Tulane University Of Louisiana · U19 · FY2016 · AI
Small Molecule Inhibitors of Ebola Virus Polymerase Function
$770,311Christopher F Basler · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AI
Vaccines and Therapeutics for Anthrax
$770,304Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI